You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

tertiary lymphoid structure

Showing 1 - 25 of 4,447
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Advanced Solid Tumor Trial in Bordeaux (MEDI5752)

Not yet recruiting
  • Advanced Solid Tumor
  • Bordeaux, France
    Institut Bergonie
May 24, 2023

Adult Soft Tissue Sarcoma, Non Small Cell Lung Cancer, Triple Negative Breast Cancer Trial in France (Ezabenlimab + BI907828)

Not yet recruiting
  • Adult Soft Tissue Sarcoma
  • +4 more
  • Ezabenlimab + BI907828
  • Bordeaux, France
  • +5 more
Oct 19, 2023

Autoimmune Bullous Disease Trial in Seoul (Biopsy)

Recruiting
  • Autoimmune Bullous Disease
  • Biopsy
  • Seoul, Korea, Republic of
    GangnamSeverance Hospital
Mar 14, 2022

Cancer Trial in Villejuif (Pembrolizumab, Pembrolizumab and Olaparib, Pembrolizumab adjuvant)

Not yet recruiting
  • Cancer
  • Villejuif, Val De Marne, France
    Gustave Roussy
Oct 30, 2023

Carcinoma, Renal Cell Trial in Pittsburgh (Autologous alpha-DC1/TBVA vaccine, Cabozantinib)

Not yet recruiting
  • Carcinoma, Renal Cell
  • Pittsburgh, Pennsylvania
    UPMC Department of Urology
Jan 5, 2023

HIV Trial run by the National Cancer Institute (NCI) (Acute Treatment Interruption)

Recruiting
  • HIV
  • Acute Treatment Interruption
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Jan 11, 2023

Refractory or Recurrent Solid Tumor Trial in France (Spartalizumab in Pediatric cohort, Low-dose Pazopanib in Pediatric Cohort,

Not yet recruiting
  • Refractory or Recurrent Solid Tumor
  • Spartalizumab in Pediatric cohort
  • +3 more
  • Angers, France
  • +8 more
Mar 9, 2022

Advanced Soft-tissue Sarcoma, Metastatic Soft-tissue Sarcoma Trial in France (Bintrafusp alfa, Doxorubicin)

Recruiting
  • Advanced Soft-tissue Sarcoma
  • Metastatic Soft-tissue Sarcoma
  • Bordeaux, France
  • +7 more
Dec 6, 2021

Soft Tissue Sarcoma Adult, Advanced Cancer Trial in France (Association of Nivolumab + Relatlimab, Nivolumab)

Recruiting
  • Soft Tissue Sarcoma Adult
  • Advanced Cancer
  • Bordeaux, France
  • +4 more
Feb 1, 2022

CMR-AI and Outcomes in Aortic Stenosis

Not yet recruiting
  • Aortic Stenosis
    • (no location specified)
    Nov 7, 2023

    Translation and Validation of the COMM and ASI-SR

    Not yet recruiting
    • Opioid Use
    • +3 more
    • Current Opioid Misuse Measure (COMM)-SWE
    • +11 more
    • (no location specified)
    Oct 16, 2023

    Mantle Cell Lymphoma, Peripheral T-cell Lymphoma (PTCL), Cutaneous T-cell Lymphoma (CTCL) Trial in Augusta, Nashville, Houston

    Recruiting
    • Mantle Cell Lymphoma
    • +9 more
    • L-Bcl-2 antisense oligonucleotide
    • Augusta, Georgia
    • +2 more
    Nov 18, 2022

    Helicobacter Pylori Infection in Patients With Chronic Tonsillits Trial in Sohag (Rapid urease test for h pylori)

    Recruiting
    • Helicobacter Pylori Infection in Patients With Chronic Tonsillits
    • Rapid urease test for h pylori
    • Sohag, Egypt
      Sohag university Hospital
    Oct 31, 2023

    Sacral Neuromodulation Trial (sacral neuromodulation)

    Completed
    • Sacral Neuromodulation
    • sacral neuromodulation
    • (no location specified)
    Oct 22, 2023

    A Greek-designed ERAS Protocol in Elective Craniotomy

    Recruiting
    • ERAS
    • Craniotomy
    • ERAS
    • Larissa, Greece
      University of Thessaly
    Jul 26, 2023

    Lymphoma, B-Cell, Leukemia, B-cell, Leukemia, T-Cell Trial in Cangzhou (CAR-T)

    Recruiting
    • Lymphoma, B-Cell
    • +3 more
    • CAR-T
    • Cangzhou, Hebei, China
      Cangzhou People's Hospital
    Nov 9, 2022

    Asthma Trial in Hamilton (Tezepelumab, Placebo)

    Recruiting
    • Asthma
    • Tezepelumab
    • Placebo
    • Hamilton, Ontario, Canada
      Firestone Institute for Respiratory Health
    Jan 18, 2023

    The Lymphoid Tissue Pharmacology of Antiretroviral Drugs

    Not yet recruiting
    • HIV Infection
    • Anti-HIV Agents
    • (no location specified)
    Nov 4, 2022

    T-cell Lymphoma, CLL/SLL Trial in Birmingham (Tazemetostat, Acalabrutinib and Tazemetostat)

    Not yet recruiting
    • T-cell Lymphoma
    • CLL/SLL
    • Birmingham, Alabama
      University of Alabama at Birmingham
    Aug 11, 2023

    Acute Myeloid Leukemia Trial in Duarte (procedure, drug, biological, other, radiation)

    Recruiting
    • Acute Myeloid Leukemia
    • Allogeneic Hematopoietic Stem Cell Transplantation
    • +7 more
    • Duarte, California
      City of Hope Medical Center
    Jun 8, 2022

    Relapsed Lymphoid Malignancies, Refractory Lymphoid Malignancies Trial in Bentleigh (CN1, 0.5mg/kg and CN401, 400mg, CN1, 1mg/kg

    Terminated
    • Relapsed Lymphoid Malignancies
    • Refractory Lymphoid Malignancies
    • CN1, 0.5mg/kg and CN401, 400mg
    • +4 more
    • Bentleigh, Victoria, Australia
      Monash Health - Monash Medical Centre
    Oct 20, 2022

    Distal Left Transradial Access in Coronary Procedures.

    Active, not recruiting
    • Cardiovascular Diseases
    • Cardiomyopathies
    • cardiac catheterization
    • Port Of Spain, North Central, Trinidad and Tobago
      Eric Williams Medical Sciences Complex
    Sep 2, 2023

    Philadelphia-Positive ALL Trial in Suzhou (Olverembatinib)

    Not yet recruiting
    • Philadelphia-Positive ALL
    • Suzhou, Jiangsu, China
      First Affiliated Hospital of Soochow University
    Jul 1, 2023

    Clinical Profile and Out Come of Children With Wilson's Disease

    Not yet recruiting
    • Clinical Outcome in WILSON Disease
    • 24 hour copper in urine and liver function test
    • (no location specified)
    Mar 18, 2023

    B-cell Lymphoid Malignancies Trial (ESG206)

    Not yet recruiting
    • B-cell Lymphoid Malignancies
    • (no location specified)
    Apr 10, 2023